These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
343 related articles for article (PubMed ID: 25264199)
1. FOXA1 antagonizes EZH2-mediated CDKN2A repression in carcinogenesis. Zhang Y; Tong T Biochem Biophys Res Commun; 2014 Oct; 453(1):172-8. PubMed ID: 25264199 [TBL] [Abstract][Full Text] [Related]
2. EZH2 expression in gliomas: Correlation with CDKN2A gene deletion/ p16 loss and MIB-1 proliferation index. Purkait S; Sharma V; Jha P; Sharma MC; Suri V; Suri A; Sharma BS; Sarkar C Neuropathology; 2015 Oct; 35(5):421-31. PubMed ID: 26096306 [TBL] [Abstract][Full Text] [Related]
3. Enhancer of zeste homolog 2 depletion induces cellular senescence via histone demethylation along the INK4/ARF locus. Jie B; Weilong C; Ming C; Fei X; Xinghua L; Junhua C; Guobin W; Kaixiong T; Xiaoming S Int J Biochem Cell Biol; 2015 Aug; 65():104-12. PubMed ID: 26004298 [TBL] [Abstract][Full Text] [Related]
4. Impact of OGT deregulation on EZH2 target genes FOXA1 and FOXC1 expression in breast cancer cells. Forma E; Jóźwiak P; Ciesielski P; Zaczek A; Starska K; Bryś M; Krześlak A PLoS One; 2018; 13(6):e0198351. PubMed ID: 29864144 [TBL] [Abstract][Full Text] [Related]
5. FOXA1 repression is associated with loss of BRCA1 and increased promoter methylation and chromatin silencing in breast cancer. Gong C; Fujino K; Monteiro LJ; Gomes AR; Drost R; Davidson-Smith H; Takeda S; Khoo US; Jonkers J; Sproul D; Lam EW Oncogene; 2015 Sep; 34(39):5012-24. PubMed ID: 25531315 [TBL] [Abstract][Full Text] [Related]
6. H3K9me-enhanced DNA hypermethylation of the p16INK4a gene: an epigenetic signature for spontaneous transformation of rat mesenchymal stem cells. Zheng Y; He L; Wan Y; Song J Stem Cells Dev; 2013 Jan; 22(2):256-67. PubMed ID: 22873822 [TBL] [Abstract][Full Text] [Related]
7. Inactivation of Eed impedes MLL-AF9-mediated leukemogenesis through Cdkn2a-dependent and Cdkn2a-independent mechanisms in a murine model. Danis E; Yamauchi T; Echanique K; Haladyna J; Kalkur R; Riedel S; Zhu N; Xie H; Bernt KM; Orkin SH; Armstrong SA; Neff T Exp Hematol; 2015 Nov; 43(11):930-935.e6. PubMed ID: 26118502 [TBL] [Abstract][Full Text] [Related]
8. Downregulation of Ezh2 methyltransferase by FOXP3: new insight of FOXP3 into chromatin remodeling? Shen Z; Chen L; Yang X; Zhao Y; Pier E; Zhang X; Yang X; Xiong Y Biochim Biophys Acta; 2013 Oct; 1833(10):2190-200. PubMed ID: 23688634 [TBL] [Abstract][Full Text] [Related]
9. Impaired PRC2 activity promotes transcriptional instability and favors breast tumorigenesis. Wassef M; Rodilla V; Teissandier A; Zeitouni B; Gruel N; Sadacca B; Irondelle M; Charruel M; Ducos B; Michaud A; Caron M; Marangoni E; Chavrier P; Le Tourneau C; Kamal M; Pasmant E; Vidaud M; Servant N; Reyal F; Meseure D; Vincent-Salomon A; Fre S; Margueron R Genes Dev; 2015 Dec; 29(24):2547-62. PubMed ID: 26637281 [TBL] [Abstract][Full Text] [Related]
10. FOXA1 mediates p16(INK4a) activation during cellular senescence. Li Q; Zhang Y; Fu J; Han L; Xue L; Lv C; Wang P; Li G; Tong T EMBO J; 2013 Mar; 32(6):858-73. PubMed ID: 23443045 [TBL] [Abstract][Full Text] [Related]
11. Polycomb protein EZH2 regulates tumor invasion via the transcriptional repression of the metastasis suppressor RKIP in breast and prostate cancer. Ren G; Baritaki S; Marathe H; Feng J; Park S; Beach S; Bazeley PS; Beshir AB; Fenteany G; Mehra R; Daignault S; Al-Mulla F; Keller E; Bonavida B; de la Serna I; Yeung KC Cancer Res; 2012 Jun; 72(12):3091-104. PubMed ID: 22505648 [TBL] [Abstract][Full Text] [Related]
12. Over-expression of polycomb group protein EZH2 relates to decreased expression of p16 INK4a in cholangiocarcinogenesis in hepatolithiasis. Sasaki M; Yamaguchi J; Itatsu K; Ikeda H; Nakanuma Y J Pathol; 2008 Jun; 215(2):175-83. PubMed ID: 18393368 [TBL] [Abstract][Full Text] [Related]
13. Carcinogenesis of intraductal papillary mucinous neoplasm of the pancreas: loss of microRNA-101 promotes overexpression of histone methyltransferase EZH2. Nakahara O; Takamori H; Iwatsuki M; Baba Y; Sakamoto Y; Tanaka H; Chikamoto A; Horino K; Beppu T; Kanemitsu K; Honda Y; Iyama K; Baba H Ann Surg Oncol; 2012 Jul; 19 Suppl 3():S565-71. PubMed ID: 21932133 [TBL] [Abstract][Full Text] [Related]
14. EZH2 regulates the expression of p16 in the nasopharyngeal cancer cells. Zhong J; Min L; Huang H; Li L; Li D; Li J; Ma Z; Dai L Technol Cancer Res Treat; 2013 Jun; 12(3):269-74. PubMed ID: 23289480 [TBL] [Abstract][Full Text] [Related]
15. BRCA1 and EZH2 cooperate in regulation of prostate cancer stem cell phenotype. Gorodetska I; Lukiyanchuk V; Peitzsch C; Kozeretska I; Dubrovska A Int J Cancer; 2019 Dec; 145(11):2974-2985. PubMed ID: 30968962 [TBL] [Abstract][Full Text] [Related]
16. Enhancer of zeste homolog 2 is overexpressed and contributes to epigenetic inactivation of p21 and phosphatase and tensin homolog in B-cell acute lymphoblastic leukemia. Chen J; Li J; Han Q; Sun Z; Wang J; Wang S; Zhao RC Exp Biol Med (Maywood); 2012 Sep; 237(9):1110-6. PubMed ID: 22956625 [TBL] [Abstract][Full Text] [Related]
17. EZH2-mediated concordant repression of Wnt antagonists promotes β-catenin-dependent hepatocarcinogenesis. Cheng AS; Lau SS; Chen Y; Kondo Y; Li MS; Feng H; Ching AK; Cheung KF; Wong HK; Tong JH; Jin H; Choy KW; Yu J; To KF; Wong N; Huang TH; Sung JJ Cancer Res; 2011 Jun; 71(11):4028-39. PubMed ID: 21512140 [TBL] [Abstract][Full Text] [Related]
18. Characterization of the EZH2-MMSET histone methyltransferase regulatory axis in cancer. Asangani IA; Ateeq B; Cao Q; Dodson L; Pandhi M; Kunju LP; Mehra R; Lonigro RJ; Siddiqui J; Palanisamy N; Wu YM; Cao X; Kim JH; Zhao M; Qin ZS; Iyer MK; Maher CA; Kumar-Sinha C; Varambally S; Chinnaiyan AM Mol Cell; 2013 Jan; 49(1):80-93. PubMed ID: 23159737 [TBL] [Abstract][Full Text] [Related]
19. Histone trimethylation of the p53 gene by expression of a constitutively active prolactin receptor in prostate cancer cells. Tan D; Tan S; Zhang J; Tang P; Huang J; Zhou W; Wu S Chin J Physiol; 2013 Oct; 56(5):282-90. PubMed ID: 24032713 [TBL] [Abstract][Full Text] [Related]
20. 20(S)-Ginsenoside Rh2 suppresses proliferation and migration of hepatocellular carcinoma cells by targeting EZH2 to regulate CDKN2A-2B gene cluster transcription. Li Q; Li B; Dong C; Wang Y; Li Q Eur J Pharmacol; 2017 Nov; 815():173-180. PubMed ID: 28928088 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]